Pharmacists Slow To Dispense Lifesaving Overdose Drug
(By Anna Gorman for Kaiser Health News) Gale Dunham, a pharmacist in Calistoga, Calif., knows the devastation the opioid epidemic
Read More
Part D/Prescription Drugs
Roche buys precision medicine firm Ignyta for $1.7B
(By Anuja Vaidya for Becker’s Hospital Review) Roche, a global pharmaceuticals and diagnostics company, is acquiring Ignyta for $27 per share in
Read MoreChicago-area counties file opioid epidemic lawsuits: 3 things to know
(By Brian Zimmerman for Becker’s Hospital Review) Cook County and five other counties encompassing Chicago suburbs recently filed lawsuits against
Read More3 trends to watch in pharma advertising in 2018
(By Rebecca Robbins for STAT) These are boom times for the multibillion-dollar drug advertising industry — and the parade of
Read MoreSickle Cell Patients, Families And Doctors Face A ‘Fight For Everything’
(By Jenny Gold for Kaiser Health News) CHICAGO — The day before his 30th birthday, Marqus Valentine was in a
Read MoreFDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs
(By Sarah Jane Tribble for Kaiser Health News) The commissioner of the Food and Drug Administration questions whether the right
Read MoreArthritis Drugs Show How U.S. Drug Prices Defy Economics
(By Julie Appleby for Kaiser Health News) Renda Bower knows well the cost of drugs to treat rheumatoid arthritis –
Read MoreFDA approves first gene therapy targeting rare form of inherited blindness
(By Adam Feuerstein for STAT) A first-of-its-kind gene therapy received approval from the Food and Drug Administration on Tuesday to
Read MoreDrug Industry Spent Millions To Squelch Talk About High Drug Prices
(By Jay Hancock for Kaiser Health News) Facing bipartisan hostility over high drug prices in an election year, the pharma
Read MorePressure builds on the DEA to stem the supply of prescription drugs, but at what cost?
(By Lev Facher for STAT) WASHINGTON — In a bland Northern Virginia office building nestled between a Costco and a
Read More